Skip to main content
Top
Published in: Endocrine 1/2011

01-02-2011 | Original Article

Melanocortin-4 receptor gene polymorphism and the level of physical activity in men (HALS Study)

Authors: Paweł Jóźków, Małgorzata Słowińska-Lisowska, Łukasz Łaczmański, Dorota Jakubiec, Marek Mędraś

Published in: Endocrine | Issue 1/2011

Login to get access

Abstract

Melanocortin plays an important role in the energy balance in humans. Actions of melanocortin are exerted through activation of five receptors among which the melanocortin-4 receptor (MC4R) is especially abundant within the central nervous system (CNS). It has been proved that genetic variations of the MC4R gene are associated with the energy intake. Recent data has suggested that MC4R gene polymorphism might influence physical activity/energy expenditure as well. Our aim was to search for associations between MC4R polymorphisms and the level of physical activity. We genotyped MC4R in a population-based cohort of 311 men. The level of physical activity was determined with use of the International Physical Activity Questionnaire. We have found that physical effort expressed as log METs-min/week (corrected for age, BMI and educational status) was 6.61 in men declaring low, 7.56—moderate and 8.96—high level of physical activity. We have not found any associations between the C-2745T MC4R polymorphism and the level of physical activity (P = 0.53). There were no interactions between the level of physical activity and the C-2745T polymorphisms either (P = 0.47). We conclude that the C-2745T genetic polymorphism of the MC4R gene does not influence the level of physical activity in healthy, adult men.
Literature
1.
go back to reference V.J. Hruby, M. Cai, J.P. Cain et al., Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor. Curr. Top. Med. Chem. 7(11), 1107–1119 (2007)CrossRefPubMed V.J. Hruby, M. Cai, J.P. Cain et al., Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor. Curr. Top. Med. Chem. 7(11), 1107–1119 (2007)CrossRefPubMed
2.
go back to reference F. Stutzmann, V. Vatin, S. Cauchi et al., Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum. Mol. Genet. 16(15), 1837–1844 (2007)CrossRefPubMed F. Stutzmann, V. Vatin, S. Cauchi et al., Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum. Mol. Genet. 16(15), 1837–1844 (2007)CrossRefPubMed
3.
go back to reference L. Ste Marie, G.I. Miura, D.J. Marsh, K. Yagaloff, R.D. Palmiter, A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc. Natl. Acad. Sci. USA 97(22), 12339–12344 (2000)CrossRefPubMed L. Ste Marie, G.I. Miura, D.J. Marsh, K. Yagaloff, R.D. Palmiter, A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc. Natl. Acad. Sci. USA 97(22), 12339–12344 (2000)CrossRefPubMed
4.
go back to reference J. Rutanen, J. Pihlajamaki, P. Karhapaa et al., The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain. Obes. Res. 12(7), 1060–1066 (2004)CrossRefPubMed J. Rutanen, J. Pihlajamaki, P. Karhapaa et al., The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain. Obes. Res. 12(7), 1060–1066 (2004)CrossRefPubMed
5.
go back to reference J.C. Tou, C.E. Wade, Determinants affecting physical activity levels in animal models. Exp. Biol. Med. (Maywood) 227(8), 587–600 (2002) J.C. Tou, C.E. Wade, Determinants affecting physical activity levels in animal models. Exp. Biol. Med. (Maywood) 227(8), 587–600 (2002)
6.
go back to reference A.W. Thorburn, J. Proietto, Biological determinants of spontaneous physical activity. Obes. Rev. 1(2), 87–94 (2000)CrossRefPubMed A.W. Thorburn, J. Proietto, Biological determinants of spontaneous physical activity. Obes. Rev. 1(2), 87–94 (2000)CrossRefPubMed
7.
go back to reference T. Adage, A.J. Scheurink, S.F. de Boer et al., Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J. Neurosci. 21(10), 3639–3645 (2001)PubMed T. Adage, A.J. Scheurink, S.F. de Boer et al., Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J. Neurosci. 21(10), 3639–3645 (2001)PubMed
8.
go back to reference Z. Xiang, S.A. Litherland, N.B. Sorensen et al., Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 45(23), 7277–7288 (2006)CrossRefPubMed Z. Xiang, S.A. Litherland, N.B. Sorensen et al., Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 45(23), 7277–7288 (2006)CrossRefPubMed
9.
go back to reference A.A. Butler, D.L. Marks, W. Fan et al., Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat. Neurosci. 4(6), 605–611 (2001)CrossRefPubMed A.A. Butler, D.L. Marks, W. Fan et al., Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat. Neurosci. 4(6), 605–611 (2001)CrossRefPubMed
10.
go back to reference F. Stutzmann, K. Tan, V. Vatin et al., Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes 57(9), 2511–2518 (2008)CrossRefPubMed F. Stutzmann, K. Tan, V. Vatin et al., Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes 57(9), 2511–2518 (2008)CrossRefPubMed
11.
go back to reference I.S. Farooqi, G.S. Yeo, J.M. Keogh et al., Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Investig. 106(2), 271–279 (2000)CrossRefPubMed I.S. Farooqi, G.S. Yeo, J.M. Keogh et al., Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Investig. 106(2), 271–279 (2000)CrossRefPubMed
12.
go back to reference D.L. Marks, N. Ling, R.D. Cone, Role of the central melanocortin system in cachexia. Cancer. Res. 61(4), 1432–1438 (2001)PubMed D.L. Marks, N. Ling, R.D. Cone, Role of the central melanocortin system in cachexia. Cancer. Res. 61(4), 1432–1438 (2001)PubMed
13.
go back to reference R.J. Loos, T. Rankinen, A. Tremblay et al., Melanocortin-4 receptor gene and physical activity in the Quebec Family Study. Int. J. Obes. (Lond.) 29(4), 420–428 (2005)CrossRef R.J. Loos, T. Rankinen, A. Tremblay et al., Melanocortin-4 receptor gene and physical activity in the Quebec Family Study. Int. J. Obes. (Lond.) 29(4), 420–428 (2005)CrossRef
14.
go back to reference A. Rutten, H. Ziemainz, F. Schena et al., Using different physical activity measurements in eight European countries. Results of the European Physical Activity Surveillance System (EUPASS) time series survey. Public Health Nutr. 6(4), 371–376 (2003)PubMed A. Rutten, H. Ziemainz, F. Schena et al., Using different physical activity measurements in eight European countries. Results of the European Physical Activity Surveillance System (EUPASS) time series survey. Public Health Nutr. 6(4), 371–376 (2003)PubMed
15.
go back to reference F. Geller, K. Reichwald, A. Dempfle et al., Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am. J. Hum. Genet. 74(3), 572–581 (2004)CrossRefPubMed F. Geller, K. Reichwald, A. Dempfle et al., Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am. J. Hum. Genet. 74(3), 572–581 (2004)CrossRefPubMed
16.
go back to reference E.H. Young, N.J. Wareham, S. Farooqi et al., The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29563 individuals. Int. J. Obes. (Lond.) 31(9), 1437–1441 (2007)CrossRef E.H. Young, N.J. Wareham, S. Farooqi et al., The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29563 individuals. Int. J. Obes. (Lond.) 31(9), 1437–1441 (2007)CrossRef
17.
go back to reference I.M. Heid, C. Vollmert, A. Hinney et al., Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J. Med. Genet. 42(4), e21 (2005)CrossRefPubMed I.M. Heid, C. Vollmert, A. Hinney et al., Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J. Med. Genet. 42(4), e21 (2005)CrossRefPubMed
18.
go back to reference I.M. Heid, C. Vollmert, F. Kronenberg et al., Association of the MC4R V103I polymorphism with the metabolic syndrome: the KORA Study. Obesity (Silver Spring) 16(2), 369–376 (2008)CrossRef I.M. Heid, C. Vollmert, F. Kronenberg et al., Association of the MC4R V103I polymorphism with the metabolic syndrome: the KORA Study. Obesity (Silver Spring) 16(2), 369–376 (2008)CrossRef
19.
go back to reference C.L. Craig, A.L. Marshall, M. Sjostrom et al., International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports. Exerc. 35(8), 1381–1395 (2003)CrossRefPubMed C.L. Craig, A.L. Marshall, M. Sjostrom et al., International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports. Exerc. 35(8), 1381–1395 (2003)CrossRefPubMed
20.
go back to reference R. Maddison, C. Ni Mhurchu, Y. Jiang et al., International Physical Activity Questionnaire (IPAQ) and New Zealand Physical Activity Questionnaire (NZPAQ): a doubly labelled water validation. Int. J. Behav. Nutr. Phys. Act. 4, 62 (2007)CrossRefPubMed R. Maddison, C. Ni Mhurchu, Y. Jiang et al., International Physical Activity Questionnaire (IPAQ) and New Zealand Physical Activity Questionnaire (NZPAQ): a doubly labelled water validation. Int. J. Behav. Nutr. Phys. Act. 4, 62 (2007)CrossRefPubMed
21.
go back to reference E. Biernat, R. Stupnicki, B. Lebiedziński, L. Janczewska, Assessment of physical activity by applying IPAQ questionnaire. Phys. Educ. Sport. 52(2), 83–89 (2008) E. Biernat, R. Stupnicki, B. Lebiedziński, L. Janczewska, Assessment of physical activity by applying IPAQ questionnaire. Phys. Educ. Sport. 52(2), 83–89 (2008)
22.
go back to reference D. Kaleta, T. Makowiec-Dabrowska, A. Jegier, Occupational and leisure-time energy expenditure and body mass index. Int. J. Occup. Med. Environ. Health. 20(1), 9–16 (2007)CrossRefPubMed D. Kaleta, T. Makowiec-Dabrowska, A. Jegier, Occupational and leisure-time energy expenditure and body mass index. Int. J. Occup. Med. Environ. Health. 20(1), 9–16 (2007)CrossRefPubMed
23.
go back to reference R. Rzewnicki, Y. Vanden Auweele, I. De Bourdeaudhuij, Addressing overreporting on the International Physical Activity Questionnaire (IPAQ) telephone survey with a population sample. Public Health Nutr. 6(3), 299–305 (2003)CrossRefPubMed R. Rzewnicki, Y. Vanden Auweele, I. De Bourdeaudhuij, Addressing overreporting on the International Physical Activity Questionnaire (IPAQ) telephone survey with a population sample. Public Health Nutr. 6(3), 299–305 (2003)CrossRefPubMed
24.
go back to reference R.P. Troiano, D. Berrigan, K.W. Dodd et al., Physical activity in the United States measured by accelerometer. Med. Sci. Sports Exerc. 40(1), 181–188 (2008)PubMed R.P. Troiano, D. Berrigan, K.W. Dodd et al., Physical activity in the United States measured by accelerometer. Med. Sci. Sports Exerc. 40(1), 181–188 (2008)PubMed
25.
go back to reference CDC, Prevalence of self-reported physically active adults, United States, 2007. MMWR Morb. Mortal Wkly. Rep. 57(48), 1297–1300 (2008) CDC, Prevalence of self-reported physically active adults, United States, 2007. MMWR Morb. Mortal Wkly. Rep. 57(48), 1297–1300 (2008)
26.
go back to reference H. Besson, U. Ekelund, J. Luan et al., A cross-sectional analysis of physical activity and obesity indicators in European participants of the EPIC-PANACEA study. Int. J. Obes. (Lond) 33(4), 497–506 (2009)CrossRef H. Besson, U. Ekelund, J. Luan et al., A cross-sectional analysis of physical activity and obesity indicators in European participants of the EPIC-PANACEA study. Int. J. Obes. (Lond) 33(4), 497–506 (2009)CrossRef
27.
go back to reference N. Kurtze, V. Rangul, B.E. Hustvedt, Reliability and validity of the international physical activity questionnaire in the Nord-Trondelag health study (HUNT) population of men. BMC Med. Res. Methodol. 8, 63 (2008)CrossRefPubMed N. Kurtze, V. Rangul, B.E. Hustvedt, Reliability and validity of the international physical activity questionnaire in the Nord-Trondelag health study (HUNT) population of men. BMC Med. Res. Methodol. 8, 63 (2008)CrossRefPubMed
28.
go back to reference U. Ekelund, H. Sepp, S. Brage et al., Criterion-related validity of the last 7-day, short form of the International Physical Activity Questionnaire in Swedish adults. Public Health Nutr. 9(2), 258–265 (2006)CrossRefPubMed U. Ekelund, H. Sepp, S. Brage et al., Criterion-related validity of the last 7-day, short form of the International Physical Activity Questionnaire in Swedish adults. Public Health Nutr. 9(2), 258–265 (2006)CrossRefPubMed
Metadata
Title
Melanocortin-4 receptor gene polymorphism and the level of physical activity in men (HALS Study)
Authors
Paweł Jóźków
Małgorzata Słowińska-Lisowska
Łukasz Łaczmański
Dorota Jakubiec
Marek Mędraś
Publication date
01-02-2011
Publisher
Springer US
Published in
Endocrine / Issue 1/2011
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-010-9412-7

Other articles of this Issue 1/2011

Endocrine 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.